• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PIM 激酶通过调节 JAK-STAT 和 NF-κB 活性促进原发性纵隔大 B 细胞淋巴瘤的存活和免疫逃逸。

PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.

机构信息

Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

出版信息

Am J Pathol. 2021 Mar;191(3):567-574. doi: 10.1016/j.ajpath.2020.12.001. Epub 2020 Dec 8.

DOI:10.1016/j.ajpath.2020.12.001
PMID:33307035
Abstract

Primary mediastinal large B-cell lymphoma (PMBL) cells depend on the constitutive activity of NF-κB and STAT transcription factors, which drive expression of multiple molecules essential for their survival. In a molecularly related B-cell malignant tumor (classic Hodgkin lymphoma), tumor Reed-Sternberg cells overexpress oncogenic (proviral integration site for Moloney murine leukemia virus (PIM) 1, 2, and 3 kinases in a NF-κB- and STAT-dependent manner and PIMs enhance survival and expression of immunomodulatory molecules. Given the multiple overlapping characteristics of Reed-Sternberg and PMBL cells, we hypothesized that PIM kinases may be overexpressed in PMBL and involved in PMBL pathogenesis. The expression of PIM kinases in PMBL diagnostic biopsy specimens was assessed and their role in survival and immune escape of the tumor cells was determined. PIMs were abundantly expressed in primary tumors and PMBL cell lines. Inhibition of PIM kinases was toxic to PMBL cells, attenuated protein translation, and down-regulated NF-κB- and STAT-dependent transcription of prosurvival factors BCL2A1, BCL2L1, and FCER2. Furthermore, PIM inhibition decreased expression of molecules engaged in shaping the immunosuppressive microenvironment, including programmed death ligand 1/2 and chemokine (C-C motif) ligand 17. Taken together, our data indicate that PIMs support PMBL cell survival and immune escape and identify PIMs as promising therapeutic targets for PMBL.

摘要

原发性纵隔大 B 细胞淋巴瘤 (PMBL) 细胞依赖 NF-κB 和 STAT 转录因子的组成性活性,这些转录因子驱动多种对其存活至关重要的分子的表达。在分子上相关的 B 细胞恶性肿瘤(经典霍奇金淋巴瘤)中,肿瘤里德-斯特恩伯格细胞过表达致癌基因(莫洛尼鼠白血病病毒 (PIM) 1、2 和 3 激酶的前病毒整合位点),以 NF-κB 和 STAT 依赖性方式,并且 PIM 增强了肿瘤细胞的存活和免疫调节分子的表达。鉴于里德-斯特恩伯格细胞和 PMBL 细胞的多个重叠特征,我们假设 PIM 激酶可能在 PMBL 中过表达并参与 PMBL 的发病机制。评估了 PMBL 诊断性活检标本中 PIM 激酶的表达,并确定了它们在肿瘤细胞存活和免疫逃逸中的作用。PIM 在原发性肿瘤和 PMBL 细胞系中大量表达。抑制 PIM 激酶对 PMBL 细胞有毒,减弱蛋白质翻译,并下调 NF-κB 和 STAT 依赖性生存因子 BCL2A1、BCL2L1 和 FCER2 的转录。此外,PIM 抑制降低了参与塑造免疫抑制微环境的分子的表达,包括程序性死亡配体 1/2 和趋化因子 (C-C 基序) 配体 17。总之,我们的数据表明 PIM 支持 PMBL 细胞存活和免疫逃逸,并将 PIM 确定为 PMBL 的有前途的治疗靶点。

相似文献

1
PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.PIM 激酶通过调节 JAK-STAT 和 NF-κB 活性促进原发性纵隔大 B 细胞淋巴瘤的存活和免疫逃逸。
Am J Pathol. 2021 Mar;191(3):567-574. doi: 10.1016/j.ajpath.2020.12.001. Epub 2020 Dec 8.
2
Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma.PIM 激酶在 Reed-Sternberg 细胞中的表达促进了霍奇金淋巴瘤中的免疫特权和肿瘤细胞存活。
Blood. 2017 Sep 21;130(12):1418-1429. doi: 10.1182/blood-2017-01-760702. Epub 2017 Jul 11.
3
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.PIM 激酶是弥漫性大 B 细胞淋巴瘤的进展标志物和新兴治疗靶点。
Br J Cancer. 2012 Jul 24;107(3):491-500. doi: 10.1038/bjc.2012.272. Epub 2012 Jun 21.
4
Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447.PIM激酶对活化B细胞弥漫性大B细胞淋巴瘤中翻译激活的调控赋予了对PIM447抑制的敏感性。
Oncotarget. 2016 Sep 27;7(39):63362-63373. doi: 10.18632/oncotarget.11457.
5
Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.原发性纵隔大B细胞淋巴瘤中的组成型STAT6激活
Blood. 2004 Jul 15;104(2):543-9. doi: 10.1182/blood-2003-10-3545. Epub 2004 Mar 25.
6
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.IkappaB激酶的小分子抑制剂对通过基因表达谱定义的弥漫性大B细胞淋巴瘤亚组具有选择性毒性。
Clin Cancer Res. 2005 Jan 1;11(1):28-40.
7
Characterization of DLBCL with a PMBL gene expression signature.具有 PMBL 基因表达特征的弥漫性大 B 细胞淋巴瘤的特征。
Blood. 2021 Jul 15;138(2):136-148. doi: 10.1182/blood.2020007683.
8
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.PMBL 的基因组分析揭示了对 PD-1 阻断敏感的新驱动因素和机制。
Blood. 2019 Dec 26;134(26):2369-2382. doi: 10.1182/blood.2019002067.
9
The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.CD83、 fascin 和 CD23 在原发性纵隔大 B 细胞淋巴瘤与经典霍奇金淋巴瘤鉴别诊断中的应用。
Ann Diagn Pathol. 2019 Jun;40:72-76. doi: 10.1016/j.anndiagpath.2019.04.009. Epub 2019 Apr 23.
10
Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.原发性纵隔大B细胞淋巴瘤:miR-92a通过靶向FOXP1进行转录调控。
Oncotarget. 2017 Mar 7;8(10):16243-16258. doi: 10.18632/oncotarget.12988.

引用本文的文献

1
Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to Immunotherapy.抑制肿瘤相关巨噬细胞中的PIM激酶可抑制炎性小体激活并使前列腺癌对免疫疗法敏感。
Cancer Immunol Res. 2025 May 2;13(5):633-645. doi: 10.1158/2326-6066.CIR-24-0591.
2
[Clinicopathological and genetic analysis of interstitial disease-like pulmonary intravascular large B cell lymphoma].间质性疾病样肺血管内大B细胞淋巴瘤的临床病理与遗传学分析
Zhonghua Xue Ye Xue Za Zhi. 2024 Sep 14;45(9):821-826. doi: 10.3760/cma.j.cn121090-20240424-00160.
3
The role of Pim-1 kinases in inflammatory signaling pathways.
Pim-1 激酶在炎症信号通路中的作用。
Inflamm Res. 2024 Oct;73(10):1671-1685. doi: 10.1007/s00011-024-01924-2. Epub 2024 Jul 30.
4
Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors.转移性胃肠道肿瘤中克服免疫耐受的途径和分子
Front Immunol. 2024 Apr 5;15:1359914. doi: 10.3389/fimmu.2024.1359914. eCollection 2024.
5
PIM3 Kinase: A Promising Novel Target in Solid Cancers.PIM3激酶:实体癌中一个有前景的新型靶点。
Cancers (Basel). 2024 Jan 26;16(3):535. doi: 10.3390/cancers16030535.
6
Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma.PIM 家族在弥漫性大 B 细胞淋巴瘤免疫微环境中的作用及机制。
World J Surg Oncol. 2023 Mar 4;21(1):76. doi: 10.1186/s12957-023-02947-5.
7
Targeting PIM Kinases to Improve the Efficacy of Immunotherapy.靶向 PIM 激酶以提高免疫疗法的疗效。
Cells. 2022 Nov 21;11(22):3700. doi: 10.3390/cells11223700.
8
Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans.在小鼠、雪貂和人类中流感病毒感染的常见和种属特异性分子特征、网络和调控因子。
Sci Adv. 2022 Oct 7;8(40):eabm5859. doi: 10.1126/sciadv.abm5859. Epub 2022 Oct 5.
9
Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis.多细胞免疫动力学表明 PIM1 可能成为葡萄膜炎的潜在治疗靶点。
Nat Commun. 2022 Oct 4;13(1):5866. doi: 10.1038/s41467-022-33502-7.
10
The Mutation of Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma.基因变异预示原发性睾丸弥漫性大B细胞淋巴瘤预后不良。
J Inflamm Res. 2022 Mar 10;15:1757-1769. doi: 10.2147/JIR.S341355. eCollection 2022.